A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors
NCT03815084
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
pd-1 and DC-NK cells
Sponsor
Allife Medical Science and Technology Co., Ltd.
Collaborators
[object Object]
[object Object]
[object Object]